Naqi’s planned acquisition of Wisear accelerates Naqi’s efforts towards commercialization and to establish a global standard for non-invasive neural interfaces. This acquisition marks a defining ...
Neuralink's Blindsight implant has received FDA breakthrough status, aiming to restore sight by stimulating the visual cortex ...
Bridgewater Associates’ flagship money pool posted record gains, while D.E. Shaw & Co.’s strategies soared as much as 28% to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback